PAR paradigm biopharmaceuticals limited..

Paul has alluded to a partnership subject to fda approval for...

  1. 508 Posts.
    lightbulb Created with Sketch. 63
    Paul has alluded to a partnership subject to fda approval for p3.....FDa approval has now been granted..so he needs to walk the talk now....He claims there is some parties interested. He and Matt are travelling to the USA in january for discussions.....What are our chances of a deal being struck first quarter 2025 ? how might that affect the sp ?????
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.5¢
Change
0.015(5.36%)
Mkt cap ! $121.4M
Open High Low Value Volume
29.0¢ 30.3¢ 28.5¢ $148.1K 502.5K

Buyers (Bids)

No. Vol. Price($)
5 23396 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 91050 11
View Market Depth
Last trade - 12.13pm 19/09/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.